IMMUNOMODULATION BY CONTROLLING ELR+ PROINFLAMMATORY CHEMOKINES LEVELS WITH THE LONG NON-CODING RNA UMLILO

The present invention relates to methods for modulating the production of ELR+ proinflammatory chemokines in a subject or a cell using either UMLiLO IncRNA inhibitors to decrease production of ELR+ proinflammatory cytokines or using UMLILO IncRNA to increase the production of ELR+ proinflammatory cytokines. The invention also provides for the use of UMLILO IncRNA inhibitors or UMLILO IncRNA to modulate the expression of ERL+ proinflammatory cytokines.